Table 1. Factor or drug effects on promoting osteogenic differentiation of PDLSCs through MAPK pathways.
| Positively regulate osteogenic differentiation of PDLSCs | |||
|---|---|---|---|
| Factor or drug | Target | Cell source | Ref |
| Myricetin | ERK1/2 JNK p38 MAPK |
upregulate OPN, OCN, COL1A1 | Kim, Park & Choung (2018) |
| Lycium barbarum polysaccharide-glycoprotein | ERK1/2 | upregulate ALP, COL1A1 | Lai et al. (2023) |
| Berberine | ERK1/2 | upregulate FOS | Liu et al. (2018) |
| Asiatic acid | ERK1/2 | upregulate BMP2, OSX | Thamnium et al. (2023) |
| Asarylaldehyde | ERK1/2 p38 MAPK |
upregulate ALP, DMP1, OPN, COL1A1, Runx2 | Hwang, Park & Han (2021) |
| Naringin | ERK1/2 | upregulate ALP, OCN, Runx2 | Wei et al. (2017) |
| 20-hydroxyecdysone | ERK1/2 | upregulate BMP2 | Jian et al. (2013) |
| Oxytocin | ERK1/2 | upregulate ALP, COL1A1, OCN, OPN, Runx2 | Ge et al. (2019) |
| Hypoxia | ERK1/2 p38 MAPK |
upregulate ALP, Sp7, Runx2, PGE2, VEGF | Wu et al. (2013) |
| Nitric oxide | JNK | upregulate ALP, Runx2, OPN, OSX downregulateLPL, PPARγ2, C/EBP |
Yang et al. (2018) |
| Light-emitting diode | ERK1/2 | upregulate ALP, OSX, OCN, Runx2 | Yamauchi et al. (2018) |
| Gold nanoparticles | p38 MAPK | upregulate ALP, COL1A1, OSX, RUNX2 | Niu et al. (2017) |
| Magnetic Stimulation | ERK1/2 | upregulate ALP | Peluso et al. (2021) |
| TGF-β3 | p38 MAPK | upregulate ALP | Li et al. (2019) |
| BMP-2/6/7/9 | JNK p38 MAPK ERK5 |
upregulate ALP, OCN, OPN, OSX, RUNX2 | Hakki et al. (2014), Jiang et al. (2016), Wang et al. (2017), Ye et al. (2014) |
| Progranulin | ERK1/2 JNK |
upregulate ALP, RUNX2 | Chen et al. (2020) |
| Dentin matrix protein 1 | ERK1/2 | upregulate ALP down-regulateTwist1 |
Chandrasekaran et al. (2013) |
| Growth arrest specific transcript 5 | JNK p38 MAPK |
upregulate growth differentiation factor 5 | Yang et al. (2020) |
| Histone methyltransferase PRDM9 | ERK1/2 JNK p38 MAPK |
upregulate ALP | Zhao et al. (2024) |